3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
7
Gastrointestinal
4
Tumor-Agnostic
3
Dermatologic
2
Breast
2
Sarcoma
1
NET
1
Gynecologic
1
Genitourinary
1
Endocrine
1
Conditions
Neuroendocrine Tumors
2
Neoplasm Metastasis
1
Interventions
Everolimus
3
tislelizumab
1
surufatinib
1
romidepsin
1
regorafenib
1
pembrolizumab
1
pasireotide
1
lutetium Lu 177 dotatate
1
folfirinox
1
fludarabine phosphate
1
epothilone B
1
cixutumumab
1
Surgical Procedures, Operative
1
Sunitinib
1
Specimen Handling
1
Radiosurgery
1
Octreotide
1
Magnetic Resonance Spectroscopy
1
Liver Transplantation
1
Lactones
1
LY2584702
1
Interleukin-13
1
Granulocyte Colony-Stimulating Factor
1
Fluorodeoxyglucose F18
1
Filgrastim
1
Erlotinib Hydrochloride
1
Embolization, Therapeutic
1
Doxorubicin
1
Depsipeptides
1
Cytokines
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
Surgical Procedures, Operative
×
NET
×
Clear all
NCT04066322
2019-09-24
RMPanNET
Fudan University
Unknown
180 enrolled